In summary, while both Retatrutide and Tirzepatide are highly effective for weight loss, Retatrutides triple agonism and superior clinical trial results make it a potentially more powerful option for patients seeking significant weight loss.
Participants were randomized 2:1 to once-weekly subcutaneous semaglutide 2.4 mg or placebo, both administered alongside lifestyle intervention
Tweak diet, supplement dose, or introduce targeted therapy if markers stay elevated
TrimRx coverage is mostly in specialty health publications and review-roundup articles
The combination addresses separate metabolic pathways semaglutide reduces caloric intake, Lipo B optimises fat oxidation but the effect is complementary, not synergistic
Whether you enjoy yoga, walking, dancing or weightlifting, it's worth weaving some form of physical activity into your routine